MED-EL USA announced FDA approval today for the company’s cochlear implant for single-sided deafness (SSD) and asymmetric hearing loss (AHL). Research supporting this change in indications for children (5 years+) and adults was reported in an ACI Alliance white paper authored by UNC staff
The mission of the American Cochlear Implant (ACI) Alliance is to advance access to the gift of hearing provided by cochlear implantation through research, advocacy and awareness.
Email to a Friend